Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1

BMC Medical Genetics

Volumn 15, Issue 1, 2014, Pages

  Xu, Wei ^a   Cohen Woods, Sarah ^b   Chen, Qian ^c   Noor, Abdul ^d   Knight, Jo ^a,d   Hosang, Georgina ^b   Parikh, Sagar V ^a,d   De Luca, Vincenzo ^d   Tozzi, Federica ^f,j   Muglia, Pierandrea ^f,g,j   Forte, Julia ^f,j   McQuillin, Andrew ^h   Hu, Pingzhao ⁱ   Gurling, Hugh M D ^h   Kennedy, James L ^a,d   McGuffin, Peter ^b   Farmer, Anne ^b   Strauss, John ^a,d   Vincent, John B ^a,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c CANCER CARE ONTARIO   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f GSK   (Italy)

^g NeuroSearch   (Denmark)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j GLAXOSMITHKLINE   (United Kingdom)

more..

Author keywords

Case control; Pathway analysis; Transmission disequilibrium test; Trio

Indexed keywords

CALCIUM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTAMATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ARTICLE; BIPOLAR DISORDER; CALCIUM SIGNALING; CANADA; CDH13 GENE; CNTNAP5 GENE; CONTROLLED STUDY; CSMD1 GENE; ETHNICITY; FAMILY STUDY; FEMALE; GENE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL; NERVE FIBER; NEUROPATHIC PAIN; PPP2R2C GENE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TMCO1 GENE; UNITED KINGDOM; ZNF659 GENE;

EID: 84891512242     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-15-2     Document Type: Article

References (69)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, USA: American Psychiatric Association, 4, Text Revision (DSM-IV-TR®), American Psychiatric Association.
2. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511-2518. 10.1001/jama.1990.03450190043026, 2232018.
3. Pini S, De Queiroz V, Pagnin D, Pezawas L, Angst J, Cassano GB, Wittchen HU. Prevalence and burden of bipolar disorders in European countries. Eur Psychopharmacol 2005, 15:425-434.
4. Sajatovic M. Bipolar disorder: disease burden. Am J Manag Care 2005, 11(Suppl 3):S80-S84.
5. McGuffin P, Katz R. The genetics of depression and manic-depressive disorder. Br J Psychiatry 1989, 155:294-304.
6. Craddock N, Jones I. Genetics of bipolar disorder. J Med Genet 1999, 36:585-594. 1762980, 10465107.
7. Craddock N, Forty L. Genetics of affective (mood) disorders. Eur J Hum Genet 2006, 14:660-668. 10.1038/sj.ejhg.5201549, 16721402.
8. Kendler KS. Preparing for gene discovery: a further agenda for psychiatry. Arch Gen Psychiatry 1999, 56:554-555. 10.1001/archpsyc.56.6.554, 10359471.
9. Rutter M, Plomin R. Opportunities for psychiatry from genetic findings. Br J Psychiatry 1997, 171:209-219. 10.1192/bjp.171.3.209, 9337969.
10. Lee KW, Woon PS, Teo YY, Sim K. Genome wideassociation studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt?. Neurosci Bio behav Rev 2012, 36:556-557.
11. Tozzi F, Manchia M, Galwey NW, Severino G, Del Zompo M, McGuffin P, Kennedy JL, Reid I, Day R, Vincent J, Farmer A, Muglia P. Admixture analysis of bipolar disorder age at onset. Psychiatry Res 2011, 185:27-32. 10.1016/j.psychres.2009.11.025, 20580841.
12. Mundo E, Zai G, Lee L, Parikh SV, Kennedy JL. The 5HT1Dbeta receptor gene in bipolar disorder: a family-based association study. Neuropsychopharmacology 2001, 25:608-613. 10.1016/S0893-133X(01)00259-7, 11557174.
13. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990, 47:589-593. 10.1001/archpsyc.1990.01810180089012, 2190539.
14. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982, 39:879-883. 10.1001/archpsyc.1982.04290080001001, 7103676.
15. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991, 48:764-770. 10.1001/archpsyc.1991.01810320088015, 1883262.
16. Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Schosser A, Ball HA, Tozzi F, Perry J, Muglia P, Kennedy JL, King N, Vincent JB, Parikh SV, Strauss J, Craig IW, McGuffin P, Farmer A. Association analysis of DAOA and DAO in bipolar disorder: results from two independent case-control studies. Bipolar Disord 2010, 12:579-581. 10.1111/j.1399-5618.2010.00837.x, 20712760.
17. Carter TD, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003, 37:297-303. 10.1016/S0022-3956(03)00052-9, 12765852.
18. Müller DJ, de Luca V, Sicard T, King N, Strauss J, Kennedy JL. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry 2006, 189:317-323. 10.1192/bjp.bp.105.010587, 17012654.
19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
20. Patterson N, Price AL, Reich D. Population Structure and Eigenanalysis. PLoS Genet 2006, 2:e190. 10.1371/journal.pgen.0020190, 1713260, 17194218.
21. Laird NM, Lange C. Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet 2006, 7:385-394.
22. Browning B, Browning S. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet 2009, 84:210-223. 10.1016/j.ajhg.2009.01.005, 2668004, 19200528.
23. HapMap3 phasing data ftp://ftp.ncbi.nlm.nih.gov/hapmap//phasing/2009-02_phaseIII/HapMap3_r2/CEU/TRIOS/.
24. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulindependent diabetes mellitus (IDDM). Am J Hum Genet 1993, 52:506-516. 1682161, 8447318.
25. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002, 21:35-50. 10.1002/sim.973, 11782049.
26. Gauderman WJ. Candidate gene association studies for a quantitative trait, using parent-offspring trios. Genet Epidemiol 2003, 25:327-338. 10.1002/gepi.10262, 14639702.
27. Kazeem GR, Farrall M. Integrating case-control and TDT studies. Ann Hum Genet 2005, 69:329-335. 10.1046/J.1469-1809.2005.00156.x, 15845037.
28. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans DM, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, et al. WellcomeTrust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium(TASC) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007, 39:1329-1337. 10.1038/ng.2007.17, 2680141, 17952073, WellcomeTrust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium(TASC).
29. Scott LJ, Muglia P, Upmanyu R, Guan W, Flickinger M, Kong X, Tozzi F, Li J, Burmeister M, Absher D, Thompson RC, Francks C, Meng F, Antoniades A, Southwick AM, Schatzberg A, Bunney W, Barchas J, Jones E, Day R, Matthews K, McGuffin P, Kennedy JL, Middleton L, Roses A, Watson SJ, Vincent J, Myers RM, Farmer A, Akil H, et al. Genome-wide association and meta-analysis of bipolar disorder in European ancestry samples. Proc Natl Acad Sci USA 2009, 106:7501-7506. 10.1073/pnas.0813386106, 2678639, 19416921.
30. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N, Edenberg HJ, Nurnberger JI, Rietschel M, Blackwood D, Corvin A, Flickinger M, Guan W, Mattingsdal M, McQuillin A, Kwan P, Wienker TF, Daly M, Dudbridge F, Holmans PA, Lin D, Burmeister M, Greenwood TA, Hamshere ML, Muglia P, Smith EN, Zandi PP, Nievergelt CM, McKinney R, Shilling PD, et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011, 43:977-983. 10.1038/ng.943, 3637176, 21926972.
31. McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, Detera-Wadleigh SD, Steele CJM, Breuer R, Strohmaier J, Wendland JR, Mattheisen M, Muhleisen TW, Maier W, Nothen MM, Cichon S, Farmer A, Vincent JB, Holsboer F, Preisig M, Rietschel M. The Bipolar Disorder Genetics (BiGs) Consortium: Meta-analysis of genome-wide association data detects a risk locus for major mood disorders on chromosome 3p21.1. Nat Genet 2010, 42:128-131. 10.1038/ng.523, 2854040, 20081856.
32. Francks C, Muglia P, Tozzi F, Farmer A, Vincent JB, Rujescu D, St Clair D. Population-based linkage analysis of schizophrenia and bipolar case-control cohorts identifies a potential susceptibility locus on 19q13. Mol Psychiatry 2010, 15:319-325. 10.1038/mp.2008.100, 18794890.
33. Beyene J, Hu P, Hamid JS, Parkhomenko E, Paterson AD, Tritchler D. athway-based analysis of measures of explained variation in a genome-wide case-control association study of rheumatoid arthritis. BMC Proc 2009, 3(Suppl7):S128. 2795901, 20017994.
34. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995, 57:289-300.
35. Liu Y, Blackwood DH, Caesar S, De Geus EJ, Farmer A, Ferreira MA, Ferrier IN, Fraser C, Gordon-Smith K, Green EK, Grozeva D, Gurling HM, Hamshere ML, Heutink P, Holmans PA, Hoogendijk WJ, Hottenga JJ, Jones L, Jones IR, Kirov G, Lin D, McGuffin P, Moskvina V, Nolen WA, Perlis RH, Posthuma D, Scolnick EM, Smit AB, Smit JH, Smoller JW, et al. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 2011, 16:2-4. 10.1038/mp.2009.107, 3883627, 20351715.
36. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008, 40:1056-1058. 10.1038/ng.209, 2703780, 18711365.
37. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008, 13:558-569. 10.1038/sj.mp.4002151, 3777816, 18317468.
38. Borsotto M, Cavarec L, Bouillot M, Romey G, Macciardi F, Delaye A, Nasroune M, Bastucci M, Sambucy JL, Luan JJ, Charpagne A, Jouët V, Léger R, Lazdunski M, Cohen D, Chumakov I. PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder. Pharmacogenomics J 2007, 7:123-132. 10.1038/sj.tpj.6500400, 16733521.
39. Kim S, Webster MJ. Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 2011, 16:452-461. 10.1038/mp.2010.23, 20308991.
40. Porteous DJ, Thomson P, Brandon NJ, Millar JK. The genetics and biology of DISC1-an emerging role in psychosis and cognition. Biol Psychiatry 2006, 60:123-131. 10.1016/j.biopsych.2006.04.008, 16843095.
41. Pickard BS, Thomson PA, Christoforou A, Evans KL, Morris SW, Porteous DJ, Blackwood DH, Muir WJ. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr Genet 2007, 17:129-133. 10.1097/YPG.0b013e328014492b, 17417055.
42. Fatemi SH, King DP, Reutiman TJ, Folsom TD, Laurence JA, Lee S, Fan YT, Paciga SA, Conti M, Menniti FS. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr Res 2008, 101:36-49. 10.1016/j.schres.2008.01.029, 18394866.
43. Guan F, Zhang C, Wei S, Zhang H, Gong X, Feng J, Gao C, Su R, Yang H, Li S. Association of PDE4B polymorphisms and schizophrenia in Northwestern Han Chinese. Hum Genet 2012, 131:1047-1056. 10.1007/s00439-011-1120-8, 22160351.
44. Kähler AK, Otnaess MK, Wirgenes KV, Hansen T, Jönsson EG, Agartz I, Hall H, Werge T, Morken G, Mors O, Mellerup E, Dam H, Koefod P, Melle I, Steen VM, Andreassen OA, Djurovic S. Association study of PDE4B gene variants in Scandinavian schizophrenia and bipolar disorder multicenter case-control samples. Am J Med Genet Part B 2010, 153B:86-96.
45. Craddock N, McGuffin P, Owen M. Darier's disease cosegregating with affective disorder. Br J Psychiatry 1994, 165:272.
46. Ewald H, Mors O, Flint T, Kruse TA. Linkage analysis between manic depressive illness and the region on chromosome 12q involved in Darier'sdisease. Psychiatr Genet 1994, 4:195-200. 10.1097/00041444-199400440-00001, 7712114.
47. Dawson E, Parfitt E, Roberts Q, Daniels J, Lim L, Sham P, Nöthen M, Propping P, Lanczik M, Maier W, Reuner U, Weissenbach J, Gill M, Powell J, McGuffin P, Owen M, Craddock N. Linkage studies of bipolar disorder in the region of the Darier'sdisease gene on chromosome 12q23-24.1. Am J Med Genet 1995, 60:94-102. 10.1002/ajmg.1320600203, 7485258.
48. Ewald H, Degn B, Mors O, Kruse TA. Significant linkage between bipolar affective disorder and chromosome 12q24. Psychiatr Genet 1998, 8:131-140. 10.1097/00041444-199800830-00002, 9800214.
49. Jones I, Jacobsen N, Green EK, Elvidge GP, Owen MJ, Craddock N. Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease. Mol Psychiatry 2002, 7:424-427. 10.1038/sj.mp.4000989, 11986988.
50. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nöthen MM, Georgi A, Schumacher J, Schwarz M, AbouJamra R, Höfels S, Propping P, Satagopan J, Detera-Wadleigh SD, Hardy J, McMahon FJ. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008, 13:197-207. 10.1038/sj.mp.4002012, 2527618, 17486107.
51. Håvik B, Le Hellard S, Rietschel M, Lybæk H, Djurovic S, Mattheisen M, Mühleisen TW, Degenhardt F, Priebe L, Maier W, Breuer R, Schulze TG, Agartz I, Melle I, Hansen T, Bramham CR, Nöthen MM, Stevens B, Werge T, Andreassen OA, Cichon S, Steen VM. The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol Psychiatry 2011, 70:35-42. 10.1016/j.biopsych.2011.01.030, 21439553.
52. Kwon E, Wang W, Tsai LH. Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol Psychiatry Epub ahead of print.
53. Munkholm K, Vinberg M, VedelKessing L. Cytokines in bipolar disorder: A systematic review and meta-analysis. J Affect Disord 2013, 144:16-27. 10.1016/j.jad.2012.06.010, 22749156.
54. Kraus DM, Elliott GS, Chute H, Horan T, Pfenninger KH, Sanford SD, Foster S, Scully S, Welcher AA, Holers VM. CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol 2006, 176:4419-4430.
55. Gunnersen JM, Kim MH, Fuller SJ, De Silva M, Britto JM, Hammond VE, Davies PJ, Petrou S, Faber ES, Sah P, Tan SS. Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons. Neuron 2001, 56:621-639.
56. Gendrel M, Rapti G, Richmond JE, Bessereau JL. A secreted complement- control-related protein ensures acetylcholine receptor clustering. Nature 2009, 461:992-996. 10.1038/nature08430, 19794415.
57. Choi KH, Elashoff M, Higgs BW, Song J, Kim S, Sabunciyan S, Diglisic S, Yolken RH, Knable MB, Torrey EF, Webster MJ. Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry 2008, 8:87. 10.1186/1471-244X-8-87, 2585075, 18992145.
58. Caberlotto L, Hurd YL. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport 1999, 10:1747-1750. 10.1097/00001756-199906030-00022, 10501568.
59. Rajgor D, Mellad JA, Autore F, Zhang Q, Shanahan CM. Multiple novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular scaffolds. PLoS One 2012, 7:e40098. 10.1371/journal.pone.0040098, 3388047, 22768332.
60. Cottrell JR, Borok E, Horvath TL, Nedivi E. CPG2: a brain- and synapse-specific protein that regulates the endocytosis of glutamine receptors. Neuron 2004, 44:677-690. 3065105, 15541315.
61. Djurovic S, Gustafsson O, Mattingsdal M, Athanasiu L, Bjella T, Tesli M, Agartz I, Lorentzen S, Melle I, Morken G, Andreassen OA. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J Affect Disord 2010, 126:312-316. 10.1016/j.jad.2010.04.007, 20451256.
62. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC, Howie B, Leung HT, Hartmann AM, Möller HJ, Morris DW, Shi Y, Feng G, Hoffmann P, Propping P, Vasilescu C, Maier W, Rietschel M, Zammit S, Schumacher J, Quinn EM, Schulze TG, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40:1053-1055. 10.1038/ng.201, 18677311.
63. Christoforou A, McGhee KA, Morris SW, Thomson PA, Anderson S, McLean A, Torrance HS, Le Hellard S, Pickard BS, StClair D, Muir WJ, Blackwood DH, Porteous DJ, Evans KL. Convergence of linkage, association and GWAS findings for a candidate region for bipolar disorder and schizophrenia on chromosome 4p. Mol Psychiatry 2011, 16:240-242. 10.1038/mp.2010.25, 20351716.
64. Ollila HM, Soronen P, Silander K, Palo OM, Kieseppä T, Kaunisto MA, Lönnqvist J, Peltonen L, Partonen T, Paunio T. Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort. Mol Psychiatry 2009, 14:351-353. 10.1038/mp.2008.122, 2694406, 19308021.
65. Pagnamenta AT, Bacchelli E, de Jonge MV, Mirza G, Scerri TS, Minopoli F, Chiocchetti A, Ludwig KU, Hoffmann P, Paracchini S, Lowy E, Harold DH, Chapman JA, Klauck SM, Poustka F, Houben RH, Staal WG, Ophoff RA, O'Donovan MC, Williams J, Nöthen MM, Schulte-Körne G, Deloukas P, Ragoussis J, Bailey AJ, Maestrini E, Monaco AP. International Molecular Genetic Study Of Autism Consortium Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol Psychiatry 2010, 68:320-328. 10.1016/j.biopsych.2010.02.002, 2941017, 20346443, International Molecular Genetic Study Of Autism Consortium.
66. Qin Z, Ren F, Xu X, Ren Y, Li H, Wang Y, Zhai Y, Chang Z. ZNF536, a novel zinc finger protein specifically expressed in the brain, negatively regulates neuron differentiation by repressing retinoic acid-induced gene transcription. Mol Cell Biol 2009, 29:3633-3643. 10.1128/MCB.00362-09, 2698762, 19398580.
67. Backx L, Vermeesch J, Pijkels E, de Ravel T, Seuntjens E, Van Esch H. PPP2R2C, a gene disrupted in autosomal dominant intellectual disability. Eur J Med Genet 2010, 53:239-243. 10.1016/j.ejmg.2010.06.006, 20601260.
68. OMIM http://omim.org/.
69. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. International Schizophrenia Consortium Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752. International Schizophrenia Consortium.